Skip to main content
Year archive

ADALTA LIMITED — 2023 filings

All 98 regulatory filings released by ADALTA LIMITED (1AD) in 2023, sourced directly from the official regulator.

98 Filings
2023 Period
2023 filings (98)
Filing Released Lang
Change of Director's Interest Notice (TO) 4 pages 275.8KB
Director's Dealing
2023-12-19 English
Change of Director's Interest Notice x 4 (TO, PM, DF & RP) 13 pages 524.7KB
Director's Dealing
2023-12-18 English
Application for quotation of securities - 1AD 6 pages 27.7KB
Capital/Financing Update
2023-12-18 English
Application for quotation of securities - 1AD 7 pages 30.3KB
Share Issue/Capital Change
2023-12-18 English
Application for quotation of securities - 1AD 6 pages 27.7KB
Capital/Financing Update
2023-12-18 English
New malaria inhibiting i-body 3 pages 202.9KB
Regulatory Filings
2023-12-18 English
AdAlta launches new InvestorHub 2 pages 189.5KB
Regulatory Filings
2023-12-17 English
Chair address to EGM 3 pages 182.9KB
AGM Information
2023-12-13 English
Results of Meeting 3 pages 185.2KB
Declaration of Voting Results & Voting Rights Announcements
2023-12-13 English
Investor Webinar Presentation 2 pages 159.0KB
Investor Presentation
2023-11-22 English
Chair address and CEO presentation to AGM 31 pages 7.5MB
AGM Information
2023-11-21 English
Results of Meeting 4 pages 174.2KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-21 English
AD-214 Phase I extension clinical study - interim results 3 pages 189.3KB
Regulatory Filings
2023-11-20 English
Becoming a substantial holder 4 pages 408.5KB
Major Shareholding Notification
2023-11-19 English
Change in substantial holding 3 pages 160.1KB
Regulatory Filings
2023-11-15 English
Letter to Shareholders, Notice of EGM & Proxy Form 25 pages 646.8KB
Proxy Solicitation & Information Statement
2023-11-14 English
Application for quotation of securities - 1AD 7 pages 30.2KB
Share Issue/Capital Change
2023-11-13 English
Proposed issue of securities - 1AD 5 pages 27.4KB
Capital/Financing Update
2023-11-08 English
Proposed issue of securities - 1AD 6 pages 30.1KB
Capital/Financing Update
2023-11-08 English
Update - Proposed issue of securities - 1AD 5 pages 28.1KB
Capital/Financing Update
2023-11-08 English
Update - Proposed issue of securities - 1AD 6 pages 30.5KB
Capital/Financing Update
2023-11-08 English
Oversubscribed placement result 4 pages 351.2KB
Capital/Financing Update
2023-11-06 English
Trading Halt 2 pages 395.0KB
Capital/Financing Update
2023-11-02 English
Placement to raise up to $1.23million 5 pages 370.9KB
Capital/Financing Update
2023-11-02 English
Prospectus 58 pages 879.7KB
Capital/Financing Update
2023-11-02 English
Proposed issue of securities - 1AD 5 pages 28.3KB
Capital/Financing Update
2023-11-02 English
Proposed issue of securities - 1AD 6 pages 30.5KB
Capital/Financing Update
2023-11-02 English
Quarterly Appendix 4C and Activities Report 14 pages 548.1KB
Interim / Quarterly Report
2023-10-26 English
Investor Presentation 39 pages 7.6MB
Investor Presentation
2023-10-26 English
AD-214 well tolerated in Phase I extension study 2 pages 364.5KB
Capital/Financing Update
2023-10-22 English
Letter to Shareholders, Notice of AGM & Proxy Form 36 pages 1.5MB
AGM Information
2023-10-19 English
AD-214 oral presentation at MPGPCR23 2 pages 379.4KB
Regulatory Filings
2023-10-18 English
R&D tax refund received & R&D Loan repayment terms extended 2 pages 222.2KB
Capital/Financing Update
2023-10-17 English
Investor roadshow with IPF survivor Bill van Nierop 3 pages 390.0KB
Investor Presentation
2023-10-12 English
Notification of cessation of securities - 1AD 4 pages 23.8KB
Share Issue/Capital Change
2023-10-11 English
Notification regarding unquoted securities - 1AD 6 pages 28.0KB
Share Issue/Capital Change
2023-10-11 English
Application for quotation of securities - 1AD 6 pages 28.3KB
Share Issue/Capital Change
2023-09-26 English
Cleansing Notice under Section 708A 1 page 371.4KB
Share Issue/Capital Change
2023-09-26 English
Prof Foley invited presentation AD-214 32 pages 11.6MB
Investor Presentation
2023-09-25 English
Dosing simulations support AD-214 IV product profile 5 pages 2.3MB
Regulatory Filings
2023-09-24 English
Notification of Date of 2023 AGM 2 pages 250.3KB
AGM Information
2023-09-21 English
AD-214 Phase I extension study fully enrolled 3 pages 224.9KB
Capital/Financing Update
2023-09-19 English
Preliminary Final Report 2 pages 430.6KB
Earnings Release
2023-08-24 English
Annual Report to shareholders 62 pages 2.8MB
Annual Report
2023-08-24 English
Appendix 4G and Corporate Governance Statement 30 pages 770.7KB
Regulatory Filings
2023-08-24 English
Investor webinar - recent AD-214 progress 2 pages 356.4KB
Investor Presentation
2023-08-06 English
AD-214 returns to clinic 2 pages 410.5KB
Capital/Financing Update
2023-08-03 English
Change in substantial holding 3 pages 149.5KB
Major Shareholding Notification
2023-07-20 English
Notification of cessation of securities - 1AD 4 pages 23.8KB
Share Issue/Capital Change
2023-07-13 English
Change in substantial holding 3 pages 159.2KB
Regulatory Filings
2023-07-13 English
Quarterly Appendix 4C and Activities Report 13 pages 674.9KB
Interim / Quarterly Report
2023-07-12 English
$1.87 million raised in oversubscribed Shortfall facility 2 pages 776.6KB
Capital/Financing Update
2023-07-12 English
Investor Presentation 31 pages 6.4MB
Investor Presentation
2023-07-12 English
Application for quotation of securities - 1AD 6 pages 27.7KB
Capital/Financing Update
2023-07-12 English
Application for quotation of securities - 1AD 7 pages 29.9KB
Share Issue/Capital Change
2023-07-12 English
Cleansing Notice under Section 708A 1 page 325.0KB
Regulatory Filings
2023-07-12 English
New AD-214 data de-risks clinical studies 4 pages 607.3KB
Regulatory Filings
2023-07-06 English
AD-214 clinical trial approval 3 pages 328.3KB
Regulatory Filings
2023-06-28 English
Change of Director's Interest Notice x 2 (TO & DF) 6 pages 359.1KB
Director's Dealing
2023-05-30 English
Change in substantial holding 3 pages 163.0KB
Regulatory Filings
2023-05-30 English
Change in substantial holding 3 pages 150.7KB
Major Shareholding Notification
2023-05-30 English
Investor Summit live and recorded presentation 2 pages 281.8KB
Investor Presentation
2023-05-28 English
Application for quotation of securities - 1AD 7 pages 30.3KB
Share Issue/Capital Change
2023-05-28 English
Top 20 Option Holders & Distribution Schedule 3 pages 90.5KB
Major Shareholding Notification
2023-05-28 English
Rights Offer results 3 pages 336.0KB
Capital/Financing Update
2023-05-24 English
Investor presentation 27 pages 5.4MB
Investor Presentation
2023-05-24 English
Notice of change of exercise price of options 2 pages 286.3KB
Capital/Financing Update
2023-05-21 English
Despatch of Rights Offer documentation 2 pages 276.7KB
Capital/Financing Update
2023-05-07 English
Investor Presentation - Rights Offer Webinar 29 pages 5.6MB
Investor Presentation
2023-05-02 English
Quarterly Appendix 4C and Activities Report 11 pages 392.6KB
Interim / Quarterly Report
2023-04-27 English
Rights Offer to fund early return to clinic and growth 4 pages 323.9KB
Capital/Financing Update
2023-04-27 English
Proposed issue of securities - 1AD 14 pages 51.0KB
Capital/Financing Update
2023-04-27 English
Prospectus 57 pages 717.4KB
Capital/Financing Update
2023-04-27 English
Target Market Determination 4 pages 195.6KB
Regulatory Filings
2023-04-27 English
Letter to Optionholders 3 pages 342.0KB
Capital/Financing Update
2023-04-27 English
Letter to Eligible Shareholders 3 pages 349.3KB
Capital/Financing Update
2023-04-27 English
Application for quotation of securities - 1AD 8 pages 32.7KB
Share Issue/Capital Change
2023-04-27 English
Letter to Ineligible Foreign Shareholders 2 pages 207.1KB
Capital/Financing Update
2023-04-27 English
Notification regarding unquoted securities - 1AD 6 pages 27.8KB
Share Issue/Capital Change
2023-04-13 English
Notification of cessation of securities - 1AD 4 pages 24.1KB
Share Issue/Capital Change
2023-04-13 English
Retirement of Non-Executive Director 2 pages 274.5KB
Board/Management Information
2023-03-23 English
Final Director's Interest Notice 4 pages 219.4KB
Director's Dealing
2023-03-23 English
ShareCafe webinar presentation 3 Mar 2023 21 pages 4.4MB
Investor Presentation
2023-03-01 English
Half Yearly Report and Accounts 24 pages 712.6KB
Interim / Quarterly Report
2023-02-26 English
Spark Plus Singapore Investor Presentation 28 pages 5.2MB
Investor Presentation
2023-02-23 English
Becoming a substantial holder 3 pages 146.3KB
Major Shareholding Notification
2023-02-19 English
Application for quotation of securities - 1AD 6 pages 27.7KB
Share Issue/Capital Change
2023-02-05 English
Application for quotation of securities - 1AD 6 pages 27.7KB
Share Issue/Capital Change
2023-02-05 English
Cleansing Notice under Section 708A 1 page 328.2KB
Regulatory Filings
2023-02-05 English
Proposed issue of securities - 1AD 5 pages 27.3KB
Capital/Financing Update
2023-02-01 English
Proposed issue of securities - 1AD 5 pages 27.6KB
Capital/Financing Update
2023-02-01 English
Quarterly Appendix 4C and Activities Report 10 pages 404.3KB
Interim / Quarterly Report
2023-01-29 English
Publication highlights I-body potential in osteoporosis 2 pages 336.5KB
Regulatory Filings
2023-01-24 English
Change in substantial holding 4 pages 574.0KB
Major Shareholding Notification
2023-01-24 English
Ceasing to be a substantial holder 2 pages 228.2KB
Major Shareholding Notification
2023-01-23 English
AdAlta welcomes new substantial shareholders 2 pages 323.1KB
Major Shareholding Notification
2023-01-23 English
Change of Director's Interest Notice x 2 6 pages 347.4KB
Director's Dealing
2023-01-23 English
Second Japan patent for AD-214 2 pages 297.4KB
Regulatory Filings
2023-01-09 English